The high levels of microsatellite instability, deficiency in mismatch repair, high density of tumor-infiltrating lymphocytes, high PD-L1 expression on tumor and immune cells, absence of Galectin-3 and distinct composition of the gut microbiota were associated with response to treatment [2,3]. This evidence concerns the gene CD274 and neoplasm.